سعر يوريكنترول Uricontrol‏ 2مجم 10 اقراص 2026

Tolterodine L-tartrate 2 mg oral tablets (pharco).

• Mild to moderate antimuscarinic effects; dry mouth most common (35% vs 10% placebo); headache very common; also dyspepsia and dry eyes.International label, same formulation · electronic Medicines Compendium (eMC)

• Urinary retention; uncontrolled narrow-angle glaucoma; myasthenia gravis; hypersensitivity to tolterodine or excipients; severe ulcerative colitis; toxic megacolon.International label, same formulation · electronic Medicines Compendium (eMC)

• Use with caution in significant bladder outlet obstruction, gastrointestinal obstructive disorders (e.g. pyloric stenosis), renal impairment, hepatic disease, autonomic neuropathy, hiatus hernia and risk of decreased GI motility.International label, same formulation · electronic Medicines Compendium (eMC)
• May cause accommodation disturbances and affect reaction time; ability to drive or use machines may be impaired.International label, same formulation · electronic Medicines Compendium (eMC)

• Potent CYP3A4 inhibitors (erythromycin, clarithromycin, ketoconazole, itraconazole, antiproteases)Concomitant systemic use not recommended: raised tolterodine levels in CYP2D6 poor metabolisers with risk of overdose.electronic Medicines Compendium (eMC)
• Other antimuscarinic drugs / muscarinic agonistsAntimuscarinics may increase effects and side effects; muscarinic cholinergic agonists may reduce tolterodine's effect.electronic Medicines Compendium (eMC)

• No adequate data in pregnant women; animal studies showed reproductive toxicity; not recommended during pregnancy.International label, same formulation · electronic Medicines Compendium (eMC)
• No data on excretion into human milk; avoid during lactation.International label, same formulation · electronic Medicines Compendium (eMC)